GPT and chronic hepatitis B virus infection: Lamivudine in combination with adefovir dipivoxil was administered in 2 patients de novo to prevent the emergence of resistant mutants taking into account of their high HBV DNA levels and the lower rates of resistance and HBV DNA breakthrough as well as the higher rates of ALT normalization with de novo combination treatment in chronic hepatitis B patients[22].